Seegene, 236,901 Shares Sold Net by Individuals in Last 5 Days... Stock Price at 275,500 KRW (-3.37%)

As of 12:30 PM on the 13th, Seegene is trading at 275,500 KRW, down 3.37% from the previous day. The trading volume is 668,523 shares, which is about 62.7% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

On October 8th, Minjeong Seon, a researcher at Hana Financial Investment, stated, "In preparation for the twin-demic, demand for simultaneous diagnostic kits capable of detecting both COVID-19 and influenza viruses is expected to increase. On September 29th, export manufacturing approval for the simultaneous diagnostic kit was obtained, and exports are expected to begin in earnest in the fourth quarter. Since the turnaround in diagnostic kit exports began in August, the Songpa-gu region accounted for 37.5%. After the peak caused by the April bubble, the overall diagnostic kit exports have already started a selection process centered around the company Seegene." She set Seegene's target price at 350,000 KRW.

Over the past five days, individual investors have net sold 236,901 shares of Seegene, while foreigners and institutions have net bought 180,308 shares and 59,567 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.